These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 33301014)

  • 21. Mass severe acute respiratory coronavirus 2 (SARS-CoV-2) testing of asymptomatic healthcare personnel.
    Roberts SC; Peaper DR; Thorne CD; Sussman LS; Murray TS; Choi SJ; Pettker CM; Russi MB; Martinello RA
    Infect Control Hosp Epidemiol; 2021 May; 42(5):625-626. PubMed ID: 33487206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymptomatic SARS-CoV-2 Infections Among Persons Entering China From April 16 to October 12, 2020.
    Ren R; Zhang Y; Li Q; McGoogan JM; Feng Z; Gao GF; Wu Z
    JAMA; 2021 Feb; 325(5):489-492. PubMed ID: 33528529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 testing of pregnant women in Japan.
    Orisaka M; Kawamura H; Yoshida Y
    J Obstet Gynaecol Res; 2021 Jan; 47(1):464. PubMed ID: 33169489
    [No Abstract]   [Full Text] [Related]  

  • 24. SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector.
    Faust L; Zimmer AJ; Kohli M; Saha S; Boffa J; Bayot ML; Nsofor I; Campos L; Mashamba-Thompson T; Herrera R; Emeka E; Shrestha S; Ugarte-Gil C; Katamba A; Pambudi I; Bichara D; Calderon RI; Ahmadzada N; Safdar MA; Nikam C; Dos Santos Lázari C; Hussain H; Win MM; Than KZ; Ahumibe A; Waning B; Pai M
    Microbes Infect; 2020; 22(10):511-514. PubMed ID: 33065265
    [No Abstract]   [Full Text] [Related]  

  • 25. One-house one-person testing: Strategical plan to limit COVID-19 spread in stage three in the developing world.
    Ali SME
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):117-118. PubMed ID: 32372726
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study.
    Yassa M; Yirmibes C; Cavusoglu G; Eksi H; Dogu C; Usta C; Mutlu M; Birol P; Gulumser C; Tug N
    J Matern Fetal Neonatal Med; 2020 Nov; 33(22):3820-3826. PubMed ID: 32691641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiology of SARS-CoV-2 clusters caused by asymptomatic cases in Anhui Province, China.
    Yuan Y; He J; Gong L; Li W; Jiang L; Liu J; Chen Q; Yu J; Hou S; Shi Y; Lu S; Zhang Z; Ge Y; Sa N; He L; Wu J; Sun Y; Liu Z
    BMC Infect Dis; 2020 Dec; 20(1):930. PubMed ID: 33287717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination of covid-19: beware of surveillance bias.
    Tancredi S; Anker D; Rosella L; Chiolero A
    BMJ; 2021 Sep; 374():n2126. PubMed ID: 34479862
    [No Abstract]   [Full Text] [Related]  

  • 29. SARS-CoV-2 infection in asymptomatic healthcare workers at a clinic in Chile.
    Olmos C; Campaña G; Monreal V; Pidal P; Sanchez N; Airola C; Sanhueza D; Tapia P; Muñoz AM; Corvalan F; Hurtado S; Meneses C; Orellana A; Montecino M; Arriagada G; Bustos FJ
    PLoS One; 2021; 16(1):e0245913. PubMed ID: 33507981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of global asymptomatic SARS-CoV-2 infection and management practices from China.
    Chen Z; Wang B; Mao S; Ye Q
    Int J Biol Sci; 2021; 17(4):1119-1124. PubMed ID: 33867834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proactive screening approach for SARS-CoV-2 among healthcare workers.
    Oster Y; Wolf DG; Olshtain-Pops K; Rotstein Z; Schwartz C; Benenson S
    Clin Microbiol Infect; 2021 Jan; 27(1):155-156. PubMed ID: 32822884
    [No Abstract]   [Full Text] [Related]  

  • 32. Is oro/nasopharyngeal swab for SARS-CoV-2 detection a safe procedure? Complications observed among a case series of 4876 consecutive swabs.
    Fabbris C; Cestaro W; Menegaldo A; Spinato G; Frezza D; Vijendren A; Borsetto D; Boscolo-Rizzo P
    Am J Otolaryngol; 2021; 42(1):102758. PubMed ID: 33125901
    [No Abstract]   [Full Text] [Related]  

  • 33. The Right Kind of Pooled Testing for the Novel Coronavirus: First, Do No Harm.
    Litvak E; Dentzer S; Pagano M
    Am J Public Health; 2020 Dec; 110(12):1772-1773. PubMed ID: 32970452
    [No Abstract]   [Full Text] [Related]  

  • 34. The prevalence of asymptomatic COVID-19 infection in cancer patients. A cross-sectional study at a tertiary cancer center in New York City.
    Ibrahim M; Natarajan V; Murthy P; Meghal T; Xu Y; Wiesel O
    Cancer Treat Res Commun; 2021; 27():100346. PubMed ID: 33756172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects.
    Al-Qahtani M; AlAli S; AbdulRahman A; Salman Alsayyad A; Otoom S; Atkin SL
    Int J Infect Dis; 2021 Jan; 102():285-288. PubMed ID: 33157290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pooling samples: a testing option for SARS-CoV-2 during a supply shortage.
    Salimnia H; Mitchell R; Gundel A; Cambell A; Gammou F; Chopra T; Fairfax M
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115205. PubMed ID: 33190092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Missing Piece - SARS-CoV-2 Testing and School Reopening.
    Rafiei Y; Mello MM
    N Engl J Med; 2020 Dec; 383(23):e126. PubMed ID: 33085856
    [No Abstract]   [Full Text] [Related]  

  • 38. Universal screening for novel coronavirus disease 2019 (COVID-19) for asymptomatic parturients: May not be beneficial at this time.
    Henderson CE; Rezai S; Jackman JM
    J Med Virol; 2021 Mar; 93(3):1198-1200. PubMed ID: 32915477
    [No Abstract]   [Full Text] [Related]  

  • 39. Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing.
    Schneitler S; Jung P; Bub F; Alhussein F; Benthien S; Berger FK; Berkó-Göttel B; Eisenbeis J; Hahn D; Halfmann A; Last K; Linxweiler M; Lohse S; Papan C; Pfuhl T; Rissland J; Roth S; Schlotthauer U; Utzinger J; Smola S; Gärtner BC; Becker SL
    Ann Glob Health; 2020 Nov; 86(1):148. PubMed ID: 33262937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universal screening identifies asymptomatic carriers of SARS-CoV-2 among pregnant women in India.
    Waghmare R; Gajbhiye R; Mahajan NN; Modi D; Mukherjee S; Mahale SD
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():503-505. PubMed ID: 33393481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.